Migraine IV Treatment (Vyepti®)

Service Description

Vyepti® is a next-generation migraine treatment — now available at Esteem Life — offering proactive, long-lasting relief for chronic migraine sufferers. Administered as an intravenous infusion every 12 weeks, Vyepti® works by targeting and blocking CGRP (calcitonin gene-related peptide), a key protein involved in triggering migraine attacks. This FDA- and NHS-approved therapy has been shown to significantly reduce the frequency and severity of migraine episodes, helping patients experience more migraine-free days and a noticeable improvement in quality of life. Vyepti® is particularly well-suited for those with busy lifestyles, offering predictable, quarterly dosing that integrates seamlessly into your routine. Please note: All Vyepti® treatments require a full clinical consultation to assess suitability. Booking an appointment does not guarantee the infusion will be administered. Your clinician will guide you through the best treatment options based on your individual profile.